Item 7.01 Regulation FD Disclosure.

On January 14, 2020, Helen Sabzevari, PhD, President and CEO of Intrexon Corporation, delivered the presentation attached to this current report as Exhibit 99.1 at the 2020 J.P. Morgan Healthcare Conference.

As provided in General Instruction B.2 of Form 8-K, the information in this Item 7.01 and the exhibit furnished hereunder will not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor will they be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as will be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.




(d)    Exhibits.

 Exhibit
  No.            Description

   99.1            Presentation dated January 14, 2020

   104           Cover Page Interactive Data File (embedded within the Inline XBRL
                 document)


                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses